You are here

Amylx

Amylyx Purchases Investigational GLP-1 Drug Avexitide in Auction Deal for $35 Million

Xtalks

Mon, 07/15/24 - 11:27 pm

Eiger BioPharmaceuticals

5 Neuro Data Readouts to Watch in the Second Half of 2024

BioSpace

Mon, 07/15/24 - 11:43 am

clinical trials

Alzheimer's disease

Cerevel Therapeutics

Neumora Therapeutics

major depressive disorder

Wolfram syndrome

Vigil Neuroscience

10 clinical trials to watch in the first half of 2024

BioPharma Dive

Wed, 01/3/24 - 05:08 pm

clinical trials

Beam Therapeutics

Moderna Therapeutics

Gilead Sciences

Alnylam Pharmaceuticals

Vertex Pharmaceuticals

Amylyx ALS drug sales tick higher after fast US launch

BioPharma Dive

Mon, 08/14/23 - 10:22 am

Amylyx Augments Case for ALS Drug Ahead of PDUFA Date

BioSpace

Thu, 05/5/22 - 11:30 pm

Go or no go? Bristol’s Lag3 debut

EP Vantage

Fri, 02/25/22 - 10:21 am

Bristol Myers Squibb

Biogen leads the amyotrophic lateral sclerosis hopefuls

EP Vantage

Thu, 09/16/21 - 10:41 am

Ionis Pharmaceuticals